Royalty Pharma Financial Overview
Royalty Pharma's market cap is currently $22.28B. The company's EPS TTM is $1.173; its P/E ratio is 22.07; and it has a dividend yield of 2.28%. Royalty Pharma is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $1.27. See an overview of income statement, balance sheet, and cash flow financials.
